Kaya Holdings, Inc. (KAYS)
OTCMKTS · Delayed Price · Currency is USD
0.0142
-0.0019 (-11.80%)
Aug 22, 2025, 4:00 PM EDT
Kaya Holdings Market Cap
Kaya Holdings has a market cap or net worth of $591.88 thousand as of August 22, 2025. Its market cap has decreased by -33.27% in one year.
Market Cap
591.88K
Enterprise Value
7.57M
Revenue
14.19K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 7, 2010, Kaya Holdings's market cap has increased from 10.13K to 591.88K, an increase of 5,745.71%. That is a compound annual growth rate of 29.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 591.88K | -49.15% |
| Dec 31, 2024 | 1.16M | 24.70% |
| Dec 29, 2023 | 933.48K | -33.27% |
| Dec 30, 2022 | 1.40M | -28.34% |
| Dec 31, 2021 | 1.95M | -64.91% |
| Dec 31, 2020 | 5.56M | -45.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |